Abstract
Purpose
Clinical studies have investigated the prevalence of gestational diabetes mellitus (GDM) in women with subclinical hypothyroidism (SCH). While some studies demonstrate a clear association, others do not. It is possible this may be due to varied diagnostic criteria for SCH and the presence of thyroid antibodies (TA). We conducted a meta-analysis, separating patients diagnosed with SCH using a diagnostic cut-off <4.0 mIU/L from those diagnosed using a cut-off >4.0 mIU/L and determined the association with GDM and factored TA status into our analysis.
Methods
A computerised search of five databases including PubMed, Embase, Cochrane Library, Web of Science and CINAHL returned 787 records. Two independent reviewers assessed abstracts and full texts against pre-specified inclusion and exclusion criteria. Ten cohort studies were included in the final analysis. The diagnostic criteria for SCH and incidence of GDM were extracted from each study. Study quality and risk of bias was assessed by two reviewers.
Results
TSH levels <4.0 mIU/L for SCH diagnosis was not associated with GDM unless patients were TA positive. Studies that used a diagnostic cut-off >4.0 mIU/L saw a significant increase in the odds of GDM, regardless of TA status (OR = 1.60, 95% CI 1.33–1.93).
Conclusions
Women with TSH levels >4.0 mIU/L have an increased odds of GDM regardless of TA status but at TSH levels <4.0 mIU/L, GDM is dependent on TA status. The use of TSH levels to identify pregnancies at risk of GDM is a novel concept that warrants exploration.
Similar content being viewed by others
References
A. Jefferys, M. Vanderpump, E. Yasmin, Thyroid dysfunction and reproductive health. Obstet. Gynaecol. 17, 39–45 (2015). https://doi.org/10.1111/tog.12161
R. Negro, A. Stagnaro-Green, Diagnosis and management of subclinical hypothyroidism in pregnancy. BMJ 349, g4929 (2014). https://doi.org/10.1136/bmj.g4929
H. Ying, Y.P. Tang, Y.R. Bao, X.J. Su, X. Cai, Y.H. Li, D.F. Wang, Maternal TSH level and TPOAb status in early pregnancy and their relationship to the risk of gestational diabetes mellitus. Endocrine 54, 742–750 (2016). https://doi.org/10.1007/s12020-016-1022-6
P. Karakosta, D. Alegakis, V. Georgiou, T. Roumeliotaki, E. Fthenou, M. Vassilaki, D. Boumpas, E. Castanas, M. Kogevinas, L. Chatzi, Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J. Clin. Endocrinol. Metabol. 97, 4464–4472 (2012). https://doi.org/10.1210/jc.2012-2540
P. Kumru, E. Erdogdu, R. Arisoy, O. Demirci, A. Ozkoral, C. Ardic, A.A. Ertekin, S. Erdogan, N.N. Ozdemir, Effect of thyroid dysfunction and autoimmunity on pregnancy outcomes in low risk population. Arch. Gynecol. Obstet. 291, 1047–1054 (2015). https://doi.org/10.1007/s00404-014-3533-9
B.D. Cakmak, U.A. Turker, M. Temur, E. Ustunyurt, Pregnancy outcomes of antibody negative and untreated subclinical hypothyroidism. J. Obstet. Gynaecol. Res. 45, 810–816 (2019). https://doi.org/10.1111/jog.13925
L.M. Chen, W.J. Du, J. Dai, Q. Zhang, G.X. Si, H. Yang, E.L. Ye, Q.S. Chen, L.C. Yu, C. Zhang, X.M. Lu, Effects of subclinical hypothyroidism on maternal and perinatal outcomes during pregnancy: a single-center cohort study of a Chinese population. PloS One 9, e109364 (2014). https://doi.org/10.1371/journal.pone.0109364
J. Cleary-Goldman, F.D. Malone, G. Lambert-Messerlian, L. Sullivan, J. Canick, T.F. Porter, D. Luthy, S. Gross, D.W. Bianchi, M.E. D’Alton, Maternal thyroid hypofunction and pregnancy outcome. Obstet. Gynecol. 112, 85–92 (2008). https://doi.org/10.1097/AOG.0b013e3181788dd7
Y. Zhang, W. Sun, S. Zhu, Y. Huang, Y. Huang, Y. Gao, J. Zhang, H. Yang, X. Guo, The impact of thyroid function and TPOAb in the first trimester on pregnancy outcomes: a retrospective study in peking. J. Clin. Endocrinol. Metabol. 105, e365–e377 (2020). https://doi.org/10.1210/clinem/dgz167
L.L. Gong, H. Liu, L.H. Liu, Relationship between hypothyroidism and the incidence of gestational diabetes: a meta-analysis. Taiwan J. Obstet. Gynecol. 55, 171–175 (2016). https://doi.org/10.1016/j.tjog.2016.02.004
M. Jia, Y. Wu, B. Lin, Y. Shi, Q. Zhang, Y. Lin, S. Wang, Y. Zhang, Meta-analysis of the association between maternal subclinical hypothyroidism and gestational diabetes mellitus. Int. J. Gynaecol. Obstet. 144, 239–247 (2019). https://doi.org/10.1002/ijgo.12751
S. Maraka, N.M. Ospina, D.T. O’Keeffe, A.E. Espinosa De Ycaza, M.R. Gionfriddo, P.J. Erwin, C.C. Coddington 3rd, M.N. Stan, M.H. Murad, V.M. Montori, Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis. Thyroid 26, 580–590 (2016). https://doi.org/10.1089/thy.2015.0418
K.A. Toulis, A. Stagnaro-Green, R. Negro, Maternal subclinical hypothyroidsm and gestational diabetes mellitus: a meta-analysis. Endocrine Pract. 20, 703–714 (2014). https://doi.org/10.4158/ep13440.Ra
A. Stagnaro-Green, M. Abalovich, E. Alexander, F. Azizi, J. Mestman, R. Negro, A. Nixon, E.N. Pearce, O.P. Soldin, S. Sullivan, W. Wiersinga; American Thyroid Association Taskforce on Thyroid Disease During, P., Postpartum: Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21, 1081–1125 (2011). https://doi.org/10.1089/thy.2011.0087
E.K. Alexander, E.N. Pearce, G.A. Brent, R.S. Brown, H. Chen, C. Dosiou, W.A. Grobman, P. Laurberg, J.H. Lazarus, S.J. Mandel, R.P. Peeters, S. Sullivan, 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 27, 315–389 (2017). https://doi.org/10.1089/thy.2016.0457
T.I.M. Korevaar, The upper limit for TSH during pregnancy: why we should stop using fixed limits of 2.5 or 3.0 mU/l. Thyroid Res. 11, 5 (2018). https://doi.org/10.1186/s13044-018-0048-7
L. Mehran, M. Tohidi, F. Sarvghadi, H. Delshad, A. Amouzegar, O.P. Soldin, F. Azizi, Management of thyroid peroxidase antibody euthyroid women in pregnancy: comparison of the american thyroid association and the endocrine society guidelines. J. Thyroid. Res. 2013, 542692 (2013). https://doi.org/10.1155/2013/542692
J.E. Haddow, G.J. Knight, G.E. Palomaki, M.R. McClain, A.J. Pulkkinen, The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J. Med. Screen 11, 170–174 (2004). https://doi.org/10.1258/0969141042467340
R. Stricker, M. Echenard, R. Eberhart, M.C. Chevailler, V. Perez, F.A. Quinn, R. Stricker, Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur. J. Endocrinol. 157, 509–514 (2007). https://doi.org/10.1530/EJE-07-0249
N.S. Panesar, C.Y. Li, M.S. Rogers, Reference intervals for thyroid hormones in pregnant Chinese women. Ann. Clin. Biochem. 38(Pt 4), 329–332 (2001). https://doi.org/10.1258/0004563011900830
O.P. Soldin, D. Soldin, M. Sastoque, Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide. Ther. Drug. Monit. 29, 553–559 (2007). https://doi.org/10.1097/FTD.0b013e31815709ac
J.P. Bocos-Terraz, S. Izquierdo-Alvarez, J.L. Bancalero-Flores, R. Alvarez-Lahuerta, A. Aznar-Sauca, E. Real-Lopez, R. Ibanez-Marco, V. Bocanegra-Garcia, G. Rivera-Sanchez, Thyroid hormones according to gestational age in pregnant Spanish women. BMC Res. Notes 2, 237 (2009). https://doi.org/10.1186/1756-0500-2-237
R.K. Marwaha, S. Chopra, S. Gopalakrishnan, B. Sharma, R.S. Kanwar, A. Sastry, S. Singh, Establishment of reference range for thyroid hormones in normal pregnant Indian women. BJOG 115, 602–606 (2008). https://doi.org/10.1111/j.1471-0528.2008.01673.x
H.W. Moon, H.J. Chung, C.M. Park, M. Hur, Y.M. Yun, Establishment of trimester-specific reference intervals for thyroid hormones in Korean pregnant women. Ann. Lab. Med. 35, 198–204 (2015). https://doi.org/10.3343/alm.2015.35.2.198
C. Li, Z. Shan, J. Mao, W. Wang, X. Xie, W. Zhou, C. Li, B. Xu, L. Bi, T. Meng, J. Du, S. Zhang, Z. Gao, X. Zhang, L. Yang, C. Fan, W. Teng, Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? J. Clin. Endocrinol. Metabol. 99, 73–79 (2014). https://doi.org/10.1210/jc.2013-1674
Y.Q. Yan, Z.L. Dong, L. Dong, F.R. Wang, X.M. Yang, X.Y. Jin, L.X. Lin, Y.N. Sun, Z.P. Chen, Trimester- and method-specific reference intervals for thyroid tests in pregnant Chinese women: methodology, euthyroid definition and iodine status can influence the setting of reference intervals. Clin. Endocrinol. 74, 262–269 (2011). https://doi.org/10.1111/j.1365-2265.2010.03910.x
S. Behboudi-Gandevani, M. Amiri, R. Bidhendi Yarandi, F. Ramezani Tehrani, The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis. Diabetol. Metab. Syndr. 11, 11 (2019). https://doi.org/10.1186/s13098-019-0406-1
C.M. Tudela, B.M. Casey, D.D. McIntire, F.G. Cunningham, Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstet. Gynecol. 119, 983–988 (2012). https://doi.org/10.1097/AOG.0b013e318250aeeb
T. Mannisto, M. Vaarasmaki, A. Pouta, A.L. Hartikainen, A. Ruokonen, H.M. Surcel, A. Bloigu, M.R. Jarvelin, E. Suvanto, Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J. Clin. Endocrinol. Metabol. 95, 1084–1094 (2010). https://doi.org/10.1210/jc.2009-1904
K. Huang, Y. Xu, S. Yan, T. Li, Y. Xu, P. Zhu, F. Tao, Isolated effect of maternal thyroid-stimulating hormone, free thyroxine and antithyroid peroxidase antibodies in early pregnancy on gestational diabetes mellitus: a birth cohort study in China. Endocrine J. 66, 223–231 (2019). https://doi.org/10.1507/endocrj.EJ18-0340
M.W. Carpenter, D.R. Coustan, Criteria for screening tests for gestational diabetes. Am. J. Obstet. Gynecol. 144, 768–773 (1982). https://doi.org/10.1016/0002-9378(82)90349-0
National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National diabetes data group. Diabetes 28, 1039–1057 (1979). https://doi.org/10.2337/diab.28.12.1039
B.E. Metzger, S.G. Gabbe, B. Persson, T.A. Buchanan, P.A. Catalano, P. Damm, A.R. Dyer, A. Leiva, M. Hod, J.L. Kitzmiler, L.P. Lowe, H.D. McIntyre, J.J. Oats, Y. Omori, M.I. Schmidt,International Association of Diabetes and Pregnancy Study Groups Consensus Panel., International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33, 676–682 (2010). https://doi.org/10.2337/dc09-1848
The World Health Organisation. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res. Clin. Pract. 103, 341–363 (2014) https://doi.org/10.1016/j.diabres.2013.10.012
N.J. Blumenthal, K. Byth, C.J. Eastman, Prevalence of thyroid dysfunction and thyroid antibodies in a private obstetrical practice in Sydney. Aust. N. Z. J. Obstet. Gynaecol. 56, 307–311 (2016). https://doi.org/10.1111/ajo.12462
R. Mullur, Y.Y. Liu, G.A. Brent, Thyroid hormone regulation of metabolism. Physiol. Rev. 94, 355–382 (2014). https://doi.org/10.1152/physrev.00030.2013
L. Aghajanova, A. Stavreus-Evers, M. Lindeberg, B.M. Landgren, L.S. Sparre, O. Hovatta, Thyroid-stimulating hormone receptor and thyroid hormone receptors are involved in human endometrial physiology. Fertil. Steril. 95, 230–237 (2011). https://doi.org/10.1016/j.fertnstert.2010.06.079. 237 e231-232
G.R. Williams, Extrathyroidal expression of TSH receptor. Ann. Endocrinol. 72, 68–73 (2011). https://doi.org/10.1016/j.ando.2011.03.006
K. Ravnskjaer, A. Madiraju, M. Montminy, Role of the cAMP pathway in glucose and lipid metabolism. Handb. Exp. Pharmacol. 233, 29–49 (2016). https://doi.org/10.1007/164_2015_32
J.F. Strauss, S. Kido, R. Sayegh, N. Sakuragi, M.E. Gåfvels, The cAMP signalling system and human trophoblast function. Placenta 13, 389–403 (1992). https://doi.org/10.1016/0143-4004(92)90047-w
M. Yamaguchi, M. Kawai, K. Kishi, A. Miyake, Regulation of rat placental lactogen (rPL)-II secretion: cAMP inhibits rPL-II secretion in vitro. Eur. J. Endocrinol. 133, 342–346 (1995). https://doi.org/10.1530/eje.0.1330342
L. Chatzi, E. Plana, V. Daraki, P. Karakosta, D. Alegkakis, C. Tsatsanis, A. Kafatos, A. Koutis, M. Kogevinas, Metabolic syndrome in early pregnancy and risk of preterm birth. Am. J. Epidemiol. 170, 829–836 (2009). https://doi.org/10.1093/aje/kwp211
Acknowledgements
The Authors would like to acknowledge The Australian Department of Education Research Training Program scholarship who provided funding for NK and SY.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Consent for publication
All authors have seen a final version of this manuscript and consent to publication.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Kent, N.L., Young, S.L., Akison, L.K. et al. Is the link between elevated TSH and gestational diabetes mellitus dependant on diagnostic criteria and thyroid antibody status: a systematic review and meta-analysis. Endocrine 74, 38–49 (2021). https://doi.org/10.1007/s12020-021-02733-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-021-02733-x